DISEASE INDICATIONS: Primary Biliary Cholangitis (PBC)

MANUFACTURER: Novartis

USAGE: Oral

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Isturisa (osilodrostat) is a steroidogenesis inhibitor that treats Cushing’s disease in adults who have failed or cannot have surgery by blocking the production of cortisol.